Literature DB >> 2943713

Enhancement in the aerobic toxicity of misonidazole and SR-2508 by buthionine sulfoximine and 4-hydroxypyrazole: the role of hydrogen peroxide.

S W Tuttle, J E Biaglow, M E Varnes, L L Donahue, E P Clark, E R Epp.   

Abstract

Chronic aerobic exposure of A549 human lung carcinoma cell cultures to 0.1 mM L-buthionine-S,R-sulfoximine and 1 mM misonidazole, or 1 mM SR-2508 results in inhibition of cell growth and decreased clonogenic survival. These patterns are not apparent with the individual drug treatments. Both parameters demonstrate maximum toxicity after 72 hr in culture, which parallels the time required to deplete A549 cells of glutathione with 0.1 mM L-BSO under these growth conditions. Toxicity appears to be related to hydrogen peroxide-produced during 1 electron reduction of the nitro compounds in the presence of oxygen. A549 cells have a lowered capacity to reduce peroxide due to the effect of thiol depletion on the enzymes GSH-peroxidase and GSH-S-transferase, which require the tripeptide as a substrate. The addition of catalase, another important enzyme involved in peroxide reduction, partially reverses the observed toxicity. 4-Hydroxypyrazole, which inhibits endogenous catalase activity, causes an increase in the observed cytotoxicity. Similar effects of L-BSO and 4-hydroxypyrazole are seen for toxicity due to hydrogen peroxide being added directly to cell cultures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943713     DOI: 10.1016/0360-3016(86)90249-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord cultures.

Authors:  S T Palayoor; E A Bump; D M Saroff; J R Delfs; C Geula; L Menton-Brennan; S J Hurwitz; C N Coleman; M A Stevenson
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Decreased ability of cells overexpressing MYC proteins to reduce peroxide and hydroperoxides.

Authors:  S Tuttle; R Muschel; E Bernhard; W G McKenna; J Biaglow
Journal:  Br J Cancer Suppl       Date:  1996-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.